TP53 and cancer: As many as 20 copies of TP53 have been reported in the elephant genome (Abegglen et al. 2015; Caulin et al. 2015; Sulak et al. 2016), suggesting that the robustness conferred by additional copies of tumor suppressor genes could contribute to the decoupling of cancer risk from body size and longevity.